Anne Vanlent - Nov 30, 2022 Form 4 Insider Report for APPLIED GENETIC TECHNOLOGIES CORP (AGTC)

Role
Director
Signature
/s/ Stacie Aarestad, Attorney-in-fact
Stock symbol
AGTC
Transactions as of
Nov 30, 2022
Transactions value $
$0
Form type
4
Date filed
12/1/2022, 08:23 AM
Previous filing
Jul 1, 2022
Next filing
Jan 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGTC Stock Option (Right to Buy) Disposed to Issuer -16K -100% 0 Nov 30, 2022 Common Stock 16K $15.13 Direct F1
transaction AGTC Stock Option (Right to Buy) Disposed to Issuer -8K -100% 0 Nov 30, 2022 Common Stock 8K $7.75 Direct F1
transaction AGTC Stock Option (Right to Buy) Disposed to Issuer -10K -100% 0 Nov 30, 2022 Common Stock 10K $4.25 Direct F1
transaction AGTC Stock Option (Right to Buy) Disposed to Issuer -10K -100% 0 Nov 30, 2022 Common Stock 10K $6.90 Direct F1
transaction AGTC Stock Option (Right to Buy) Disposed to Issuer -10K -100% 0 Nov 30, 2022 Common Stock 10K $3.02 Direct F1
transaction AGTC Stock Option (Right to Buy) Disposed to Issuer -12K -100% 0 Nov 30, 2022 Common Stock 12K $4.72 Direct F1
transaction AGTC Stock Option (Right to Buy) Disposed to Issuer -14K -100% 0 Nov 30, 2022 Common Stock 14K $2.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Anne Vanlent is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option.

Remarks:

Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 23, 2022, by and among Applied Genetic Technologies Corporation (the "Issuer"), Alliance Holdco Limited ("Parent") and Alliance Acquisition Sub, Inc., a wholly owned subsidiary of Parent ("Purchaser"), on November 30, 2022, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger").